Published on
September 28, 2026
- 10:00 GMT
INNOVOTEX Expands Macrocycle Drug Conjugate Platform via Dual-Payload Technology for Tumor-Selective Combination Therapy
Provisional patent application is directed to a dual-payload MDC designed to exploit synthetic lethality in a single tumor-localizing construct AUSTIN, TX, UNITED STATES, September 28, 2026 /EINPresswire.com/ -- INNOVOTEX Inc., a privately held …
Distribution channels:
Business & Economy, Chemical Industry
...
